This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Monday's Health Winners & Losers

Option Care (OPTN) skyrocketed Monday on merger news as a few other health stocks recorded smaller gains from scattered news during a flat-to-green session.

Walgreen (WAG) will pay $19.50 a share, or some $850 million total, for Option Care, a specialty pharmacy-services company based in Buffalo Grove, Ill. Option Care bolted $3.84, or 25%, to $19.24. Walgreen was up 17 cents, or 0.4%, to $43.70.

Small-cap bio-nanotech company pSivida (PSDV - Get Report) took off in the opposite direction after announcing that it entered an agreement for a direct offering to sell its Nasdaq-traded American Depositary Shares and warrants to purchase ADSs, including $6.5 million, to Pfizer (PFE).

It estimates the net proceeds from the offering will be $16.3 million after the placement agent fees and estimated offering expenses. Shares of pSivida were down 32 cents, or 21%, to $1.20.

A few other companies had smaller moves to start the week.

San Francisco-based biopharmaceutical company Anesiva (ANSV) said Monday that preliminary follow-up data from a phase II study show that osteoarthritis treatment Adlea reduced knee pain for up to 12 weeks and continued to be well-tolerated. The company said it's on track to advance Adlea to a phase II/III trial for osteoarthritis of the knee in addition to late-stage trials in various indications this summer. Anesiva rose 35 cents, or 5.7%, to $6.50.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
ACOR $31.44 0.00%
KND $23.77 0.00%
PSDV $4.05 0.00%
SPNC $26.19 0.00%
VTR $72.32 0.00%


DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs